Literature DB >> 6242950

Comparative steady state pharmacokinetic study of piroxicam and flurbiprofen in normal subjects.

H J Rogers, R G Spector, P J Morrison, I D Bradbrook.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6242950

Source DB:  PubMed          Journal:  Eur J Rheumatol Inflamm        ISSN： 0140-1610


× No keyword cloud information.
  13 in total

Review 1.  The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.

Authors:  K W Woodhouse; H Wynne
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

2.  Enhanced elimination of piroxicam by administration of activated charcoal or cholestyramine.

Authors:  D G Ferry; L R Gazeley; W J Busby; D M Beasley; I R Edwards; A J Campbell
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Binding of a metabolite of triflusal (2-hydroxy-4-trifluoromethylbenzoic acid) to serum proteins in rat and man.

Authors:  R Mis; J Ramis; L Conte; J Forn
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 4.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

Review 5.  Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.

Authors:  K T Olkkola; A V Brunetto; M J Mattila
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

Review 6.  The problems and pitfalls of NSAID therapy in the elderly (Part II).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

Review 7.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

8.  Piroxicam and 5'-hydroxypiroxicam kinetics following multiple dose administration of piroxicam.

Authors:  C J Richardson; K L Blocka; S G Ross; R K Verbeeck
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 9.  Clinical pharmacokinetics of flurbiprofen and its enantiomers.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

Review 10.  Piroxicam: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.